Categories AlphaGraphs, Analysis, Earnings, Retail
Bed Bath & Beyond headed for a weak Q1 as margin, comps remain stressed
Bed Bath & Beyond (Nasdaq: BBBY) is one of the worst-performing Wall Street stocks, which has been on a losing streak for several years. Over the past two years, the company’s comparable store sales have remained in the negative territory, weighing down on the overall top-line performance.
The home furnishing retailer is scheduled to publish its first-quarter results on July 10 after the market’s close. Things went from bad to worse after the company provided below-consensus guidance while reporting the fourth-quarter results, sending the stock to a tailspin. Though fourth-quarter earnings of $1.20 per share came in slightly above estimates, sales dipped 11% to $3.3 billion.
The pressure on margin, mainly due to high expenses and weak store performance, is estimated to have affected earnings in the to-be-reported quarter. The management has long been under fire from activist investors for its failure to bring in innovation and stay competitive in the market. The standoff, combined with negative rating actions by leading brokerages, has dampened investor sentiment further.
The pressure on margin, mainly due to high expenses, is estimated to have affected earnings in the to-be-reported quarter
Considering the unfavorable conditions, market watchers predict a 75% year-over-year fall in first-quarter earnings to $0.08 per share, on revenues of $2.58 billion, which is down 6.3% from the year-ago period. While margins are expected to improve slightly from the previous quarter’s levels, higher operating costs and the deterioration in comparable store performance remain a cause for worry.
Having said that, the bullish outlook for the home furnishing market, in the wake of the renewed economic momentum and the uptick in consumer spending, will have a positive impact on Bed Bath & Beyond, going forward. In order to tap those benefits, special attention should be given on innovation and enhancing efficiency.
The management has the daunting task of ramping up the e-commerce platform to match the competitors, which is inevitable to turn the business around in a meaningful way. Efforts should also be made to identify non-profitable stores and close/remodel them.
Though the stock recovered from the multi-year lows seen towards the end of last year, it pared the gains in the last few months and is currently trading just above $10.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on